Neuralink faces federal probe over alleged animal abuse, “hack job” surgeries
Current and former employees blame mishaps and abuse on pressure from Musk to go faster.
Science // Science & Exploration
After lunar flyby, NASA’s Orion spacecraft is set to splash down on Sunday
NASA is now three weeks into a 25.5-day test flight of the Orion spacecraft.
Elizabeth Holmes appeals conviction, 11-year sentence despite bleak outlook
Holmes is currently scheduled to report to prison in April.
The ingenious way that marsh grass shrimp reduce drag while swimming
The shrimp flexes its legs on the recovery stroke and keeps them close together.
Pfizer seeks FDA greenlight for bivalent COVID dose in kids under 5 years
Bivalent vaccine wouldn't be a booster, but part of an updated primary series.
Respiratory illnesses slam US: “Perfect storm for a terrible holiday season”
Respiratory illnesses are slamming the US, and things could get worse.
Dmitry Rogozin may be in some trouble in Russia
Wagner Group soldiers are well-trained to identify those attired in NATO clothing.
After the Artemis I mission’s brilliant success, why is an encore 2 years away?
"I would say that we’re going to try our best to get there."
As the Arctic warms, beavers are moving in
Scientists are just beginning to study the impacts of beaver dams on the tundra.
No, physicists didn’t make a real wormhole. What they did was still pretty cool
"Don't hold your breath about sending your dog through a wormhole."
Ohio measles outbreak nearly triples, expected to last “several months”
"Don't wait. Don't wait until after the holiday. Get them vaccinated now."
After bankruptcy and war, OneWeb turns to a competitor for help
OneWeb, as ever, is doing what it needs to do to survive.
Rocket Report: SpaceX launch delayed indefinitely; Virgin Orbit cancels funding round
"Due to current market conditions, the company has elected not to proceed."
Prescription poop is here: FDA approves fecal slurry for unshakeable diarrhea
It's a win for those with C. diff and a milestone for microbiome-based therapies.
Over a year later, Musk’s Neuralink still 6 months from human trials
Lots of tech in development, but we're still waiting for indications of an application.
